For the sixth consecutive year, specialty infusion services provider Pentec Health has received recognition from Inc. magazine as one of the fastest-growing private companies in America. The pharmacy services firm is among the less than 5 percent of firms to earn inclusion in the Inc. 5000 six years in a row, and it remains one of only 12 health sector companies to achieve this feat.
Inc. magazine began creating its annual ranking of leading private companies in 1982. Since then, it has presented this distinction to such noteworthy firms as Microsoft, GoPro, Dell, and Oracle. To develop the list for 2015, the publication compared the percentage of revenue growth achieved by organizations from 2011 to 2014.
Pentec Health has maintained a growth rate of 65 percent over the past three years. Headquartered near Philadelphia, it is one of the United States’ largest private providers of outsourced pharmacy services. The company has received both domestic and international patents for its specialty infusion and renal nutrition products, as well as an ongoing Gold Seal of Approval from the Joint Commission in recognition of its dedication to safe, effective home patient care. As an Inc. 5000-commended company, Pentec Health received an invitation to attend the 34th annual Awards Ceremony and Dinner in Orlando, Florida.
Since 1996, the Jay Fund has honored the memory of Boston College football player Jay McGillis by supporting families throughout northeast Florida, New York, and New Jersey in the fight against childhood cancer. The Jay Fund is the philanthropic initiative of Super Bowl-winning head coach Tom Coughlin, whose relationship with the McGillis family inspired him to assist other families in need.
The Jay Fund assists families through a financial assistance program that helps pay for necessities such as rent, transportation, food, utilities, and other household expenses. The nonprofit’s efforts to alleviate the financial burden often caused by a cancer diagnosis include a financial literacy program called the Financial Game Plan, which it recently expanded to New York and New Jersey after years of success in Florida.
Directed by Jay Fund financial coach Robert D. VanLangen, CPA, the Financial Game Plan facilitates financial education for the Jay Fund’s families, with the dual aim of providing initial crisis management support and fostering long-term financial literacy. The program includes individual coaching sessions with Mr. VanLangen and a group seminar, Managing the Financial Challenges of Childhood Cancer, which provides not only valuable financial insight but also an opportunity for families to support each other. The Financial Game Plan additionally provides participants with Jay’s Financial Playbook, a backpack containing organizational tools to help families manage medical appointments and expenses.
Joe Cosgrove is the CEO of Pentec Health Incorporated, a specialty sterile compounding pharmacy providing services to patients in the home and other various alternate administration sites. The company is located in Boothwyn, Pennsylvania. Also the chairman of Pentec Health’s board, Joe Cosgrove manages the company’s development strategy and is largely responsible for its newest line of dietary supplements known as Proplete.
Due to its unique composition, Proplete, designed for those who experience problems after hemodialysis, provides benefits to patients with the following conditions:
Chronic Kidney Disease: An estimated 70 percent of patients with chronic kidney disease deal with malnutrition after receiving hemodialysis, which can lead to weight loss and low protein levels. Proplete provides significant doses of protein.
Fluid Management Problems: Patients with advanced cardiac or hepatic disease may experience problems with managing fluids. The low-volume nature of Proplete can help alleviate these concerns.
Obesity: Traditional hemodialysis medications often contain extra calories and lipids in addition to high levels of protein. Proplete contains no lipids and is low in carbohydrates, making it ideal for overweight or obese patients.
Diabetes: Many Intradialytic Parenteral Nutrition (IDPN) supplements require close supervision of blood glucose intake in diabetic patients. The low-dextrin formula of Proplete allows diabetic patients to more easily manage these levels.